
Recurrent Bladder Cancer in a Teenage Male
Recurrent Bladder Cancer in a Teenage Male - Beyond the Abstract June 1, 2020 There is a growing population of pediatric, adolescent, and young adult patients with urologic...
06/05/2020
- READ MORE
Recurrent Bladder Cancer in a Teenage Male - Beyond the Abstract June 1, 2020 There is a growing population of pediatric, adolescent, and young adult patients with urologic...
06/05/2020
Trinity Bivalacqua joins Ashish Kamat to discuss the role of blue light cystoscopy in bladder cancer treatment, specifically regarding non-muscle invasive disease. Dr....
06/04/2020
Low-intensity surveillance may be comparable to high-intensity surveillance for cancer control in patients with high-risk non-muscle invasive bladder cancer (NMIBC). Results...
06/02/2020
An immunotherapy drug 'avelumab' significantly improves survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial...
06/01/2020
Bladder cancer is associated with significant illness and mortality, particularly if treatment is delayed. Writing in the journal Bladder Cancer, researchers have outlined...
05/24/2020
Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes Tumour heterogeneity Abstract Histological and molecular analyses of urothelial...
05/14/2020
Bladder Cancer SHARE Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer - Beyond the Abstract May 5, 2020 Although...
05/11/2020
Let’s start with the basics. Your kidneys are two potato-shaped organs that sit behind your belly on either side of the spine. They filter your blood—straining out salt, water,...
05/07/2020
Nivolumab (Opdivo) in combination with gemcitabine and cisplatin in the neoadjuvant setting led to a pathologic nonmuscle-invasive rate of 66% and a pathologic complete response...
03/10/2020
A study published in EBioMedicine provides the first evidence from a population-based prospective cohort study of the potential of urinary telomerase reverse transcriptase...
03/01/2020
Banner Image: Dr. Neal Shore, a member of the BCAN Board of Directors, speaks with a patient about diagnosing and monitoring bladder cancer. Although radiological tests provide...
02/14/2020
On December 18, 2019, the Food and Drug Administration (FDA) granted accelerated approval to enfortumab vedotin-ejfv (Padcev) for people with advanced bladder cancer that has...
01/17/2020